You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for NDC 51754-5001


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 51754-5001

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Sodium Bicarbonate Injection (NDC: 51754-5001)

Introduction

Sodium bicarbonate injection, with the National Drug Code (NDC) 51754-5001, is a critical pharmaceutical product used in various medical settings, including critical care and the management of metabolic acidosis. This analysis will delve into the current market dynamics, supply chain issues, and price projections for this specific product.

Market Demand and Usage

Sodium bicarbonate injection is a vital medication in healthcare, particularly in critical care settings. It is used during advanced cardiac life support (ACLS), to manage metabolic acidosis and hyperkalemia, and as an antidote for certain overdoses[1].

Given its essential role, the demand for sodium bicarbonate injection remains consistent, if not increasing, due to its broad applications in emergency and critical care.

Supply Chain and Availability

The supply of sodium bicarbonate injection has been affected by several factors, including manufacturing delays and changes in market participation.

  • Manufacturing Delays: Pfizer, a major supplier, has experienced manufacturing delays, leading to shortages of various concentrations of sodium bicarbonate injection, including the 8.4% solution in 50 mL syringes and vials. Estimated resupply dates range from December 2024 to May 2025[1].
  • Market Participation: Exela Pharma Sciences, another key supplier, continues to produce and supply sodium bicarbonate injection, including the 8.4% solution in 50 mL vials (NDC: 51754-5001)[2].
  • New Entrants: Long Grove Pharmaceuticals recently launched their version of sodium bicarbonate injection, which could help alleviate some of the supply pressure[1].

Price Trends and Projections

The pricing of pharmaceuticals, including sodium bicarbonate injection, is influenced by several factors such as manufacturing costs, regulatory environment, and market competition.

Historical Price Trends

  • The pharmaceutical industry has seen significant price increases over the past few years. From January 2022 to January 2023, the average price increase for prescription drugs was 15.2%, which translates to $590 per drug product[4].
  • While sodium bicarbonate injection is not typically among the drugs with the highest dollar value increases, its price can still be affected by broader industry trends.

Current Pricing

  • The current pricing for sodium bicarbonate injection (NDC: 51754-5001) is not explicitly stated in the available sources, but it is generally influenced by the costs associated with production, distribution, and regulatory compliance.
  • Given the supply chain disruptions and the critical nature of the product, prices may be subject to fluctuations.

Price Projections

  • Short-Term: In the short term, prices for sodium bicarbonate injection may remain stable or see slight increases due to ongoing supply chain issues and manufacturing delays. The estimated resupply dates for Pfizer’s products suggest that the market may experience some price volatility until the supply stabilizes[1].
  • Long-Term: In the long term, the entry of new manufacturers like Long Grove Pharmaceuticals could lead to increased competition, potentially stabilizing or even reducing prices. Additionally, advancements in pharmaceutical technologies and outsourcing trends could improve efficiency and reduce costs, which might also impact pricing[3].

Regulatory and Safety Considerations

Regulatory and safety issues can significantly impact the pricing and availability of pharmaceuticals.

  • Recalls and Safety Alerts: Exela Pharma Sciences issued a voluntary recall of 8.4% Sodium Bicarbonate Injection USP due to sterility concerns, which can affect market confidence and pricing[5].
  • Regulatory Compliance: Ensuring compliance with FDA regulations and guidelines, such as those related to sterility and manufacturing practices, is crucial. Non-compliance can lead to recalls, fines, and increased costs, all of which can influence pricing.

Alternative Agents and Management

In cases of shortages, healthcare providers may need to consider alternative agents.

  • Sodium Acetate: This can be used as an alternative, but it requires different infusion rates compared to sodium bicarbonate, which can impact clinical practice and resource allocation[1].
  • Supply Management: Clinicians are advised to reserve sodium bicarbonate supplies for critical care uses, which can affect the overall demand and pricing dynamics.

Conclusion

The market for sodium bicarbonate injection (NDC: 51754-5001) is complex, influenced by supply chain disruptions, manufacturing delays, and regulatory considerations. Here are the key takeaways:

  • Consistent Demand: The demand for sodium bicarbonate injection remains high due to its critical applications.
  • Supply Chain Issues: Manufacturing delays and changes in market participation affect availability.
  • Price Trends: Prices may see short-term volatility due to supply issues but could stabilize or decrease with increased competition and technological advancements.
  • Regulatory and Safety Considerations: Ensuring compliance and addressing safety concerns are crucial for maintaining market stability.

Key Takeaways

  • Supply Chain Resilience: The supply chain for sodium bicarbonate injection is currently fragile due to manufacturing delays.
  • Price Volatility: Short-term price fluctuations are possible due to supply chain issues.
  • Regulatory Impact: Compliance with FDA regulations is essential for maintaining market stability.
  • Alternative Agents: Sodium acetate can be used as an alternative, but with different clinical practices.
  • Market Competition: Increased competition from new entrants could stabilize or reduce prices in the long term.

FAQs

Q: What is the current status of the supply for sodium bicarbonate injection (NDC: 51754-5001)? A: The supply is currently affected by manufacturing delays, particularly from Pfizer, but Exela Pharma Sciences and Long Grove Pharmaceuticals continue to supply the product.

Q: How do supply chain issues impact the pricing of sodium bicarbonate injection? A: Supply chain issues can lead to short-term price volatility due to reduced availability and increased demand.

Q: What are the alternative agents for sodium bicarbonate injection? A: Sodium acetate can be used as an alternative, but it requires different infusion rates.

Q: What regulatory considerations affect the pricing and availability of sodium bicarbonate injection? A: Ensuring compliance with FDA regulations, addressing safety concerns, and managing recalls can impact pricing and availability.

Q: How might new entrants in the market affect the pricing of sodium bicarbonate injection? A: New entrants like Long Grove Pharmaceuticals could increase competition, potentially stabilizing or reducing prices in the long term.

Sources

  1. ASHP: Drug Shortage Detail: Sodium Bicarbonate Injection.
  2. Exela Pharma Sciences: Pharma Products.
  3. Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024.
  4. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023.
  5. FDA: Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection USP.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.